Aspirin for Preventing Strokes in Head and Neck Injuries
Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).
Recruiting
Phase 4
Interventional Study
Blunt Cerebrovascular Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 98 (estimated)
- Sponsor
- Loma Linda University · Other
Who this trial is looking for
This trial is looking for adults with head and neck blood vessel injuries to test if a lower dose of Aspirin works as well as a higher dose in preventing strokes. Participants will take either 81 mg or 325 mg of Aspirin.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with blunt cerebrovascular injury.
You may not be able to join if
- I am under 18 years old.
- I am pregnant.
- I cannot take Aspirin by mouth.
- I am currently on a Heparin drip or other full dose blood thinners.
- I am taking other anti-platelet medications besides Aspirin.
- I have a grade 5 blunt cerebrovascular injury.
- I am allergic to Aspirin or have a contraindication to it.
- I have had an acute stroke that affects the injured area.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare difference between Aspirin 81 mg and Aspirin 325 mg in preventing strokes in patients with head and neck vessels injury.
The main questions it aims to answer are:
* If Aspirin 81 mg efficacy in prevention of stroke in patients with head and neck vessels injury is not lower than and Aspirin 325 mg.
* If rate of hemorrhagic complications in patients wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18
* All patients with blunt cerebrovascular injury are diagnosed by computed tomography angiography (CTA) upon admission
Exclusion Criteria:
* Age \<18
* Pregnant women
* No enteral route access for Aspirin administration
* Patients who are on Heparin drip or other ful…
Contacts